Viridian Therapeutics Statistics
Total Valuation
VRDN has a market cap or net worth of $1.20 billion. The enterprise value is $584.24 million.
Important Dates
The last earnings date was Tuesday, May 6, 2025, before market open.
Earnings Date | May 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
VRDN has 81.59 million shares outstanding. The number of shares has increased by 47.46% in one year.
Current Share Class | 81.59M |
Shares Outstanding | 81.59M |
Shares Change (YoY) | +47.46% |
Shares Change (QoQ) | +1.61% |
Owned by Insiders (%) | 0.04% |
Owned by Institutions (%) | 96.61% |
Float | 67.18M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3,966.13 |
Forward PS | 45.16 |
PB Ratio | 2.88 |
P/TBV Ratio | 2.88 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1,934.58 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.49, with a Debt / Equity ratio of 0.04.
Current Ratio | 19.49 |
Quick Ratio | 18.88 |
Debt / Equity | 0.04 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -110.67 |
Financial Efficiency
Return on equity (ROE) is -51.95% and return on invested capital (ROIC) is -34.19%.
Return on Equity (ROE) | -51.95% |
Return on Assets (ROA) | -32.62% |
Return on Invested Capital (ROIC) | -34.19% |
Return on Capital Employed (ROCE) | -53.73% |
Revenue Per Employee | $2,112 |
Profits Per Employee | -$1.70M |
Employee Count | 143 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.96% in the last 52 weeks. The beta is 0.46, so VRDN's price volatility has been lower than the market average.
Beta (5Y) | 0.46 |
52-Week Price Change | +18.96% |
50-Day Moving Average | 13.17 |
200-Day Moving Average | 17.80 |
Relative Strength Index (RSI) | 61.85 |
Average Volume (20 Days) | 744,720 |
Short Selling Information
The latest short interest is 10.55 million, so 12.93% of the outstanding shares have been sold short.
Short Interest | 10.55M |
Short Previous Month | 10.12M |
Short % of Shares Out | 12.93% |
Short % of Float | 15.70% |
Short Ratio (days to cover) | 12.38 |
Income Statement
In the last 12 months, VRDN had revenue of $302,000 and -$243.10 million in losses. Loss per share was -$3.33.
Revenue | 302,000 |
Gross Profit | -237.02M |
Operating Income | -337.00M |
Pretax Income | -228.06M |
Net Income | -243.10M |
EBITDA | -336.49M |
EBIT | -337.00M |
Loss Per Share | -$3.33 |
Full Income Statement Balance Sheet
The company has $636.63 million in cash and $23.11 million in debt, giving a net cash position of $613.53 million or $7.52 per share.
Cash & Cash Equivalents | 636.63M |
Total Debt | 23.11M |
Net Cash | 613.53M |
Net Cash Per Share | $7.52 |
Equity (Book Value) | 604.47M |
Book Value Per Share | 5.09 |
Working Capital | 623.51M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$279.75 million and capital expenditures -$597,000, giving a free cash flow of -$280.35 million.
Operating Cash Flow | -279.75M |
Capital Expenditures | -597,000 |
Free Cash Flow | -280.35M |
FCF Per Share | -$3.44 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -111,590.73% |
Pretax Margin | -102,092.38% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
VRDN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -47.46% |
Shareholder Yield | -47.46% |
Earnings Yield | -20.30% |
FCF Yield | -23.41% |
Analyst Forecast
The average price target for VRDN is $38.50, which is 162.26% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $38.50 |
Price Target Difference | 162.26% |
Analyst Consensus | Strong Buy |
Analyst Count | 12 |
Revenue Growth Forecast (5Y) | 409.61% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on November 13, 2020. It was a reverse split with a ratio of 0.0666666:1.
Last Split Date | Nov 13, 2020 |
Split Type | Reverse |
Split Ratio | 0.0666666:1 |
Scores
VRDN has an Altman Z-Score of 10.51.
Altman Z-Score | 10.51 |
Piotroski F-Score | n/a |